
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
The Hindu
Natco Pharma CEO discusses impact of U.S. tariffs on Indian pharma industry and strategies for diversification and growth.
More Related News

Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.












